Cargando…
Comparisons of biophysical properties and bioactivities of mono-PEGylated endostatin and an endostatin analog
BACKGROUND: Endostatin (ES) is a well-established potent endogenous antiangiogenic factor. An ES variant, called zinc-binding protein-ES (ZBP-ES), is clinically available; however, its use is limited by rapid renal clearance and short residence time. PEGylation has been exploited to overcome these s...
Autores principales: | Wang, Shan, Fu, Yan, Luo, Yongzhang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721152/ https://www.ncbi.nlm.nih.gov/pubmed/26792627 http://dx.doi.org/10.1186/s40880-016-0080-8 |
Ejemplares similares
-
Endostatin in the pancreas
por: Wigmore, S J
Publicado: (2005) -
Comparison of the antiangiogenic activity of modified RGDRGD-endostatin to endostatin delivered by gene transfer in vivo rabbit neovascularization model
por: Ge, Hong-yan, et al.
Publicado: (2011) -
Autoantibodies to endostatin in patients with breast cancer: correlation to endostatin levels and clinical outcome
por: Bachelot, T, et al.
Publicado: (2006) -
Combined BRM270 and endostatin inhibit relapse of NSCLC while suppressing lung cancer stem cell proliferation induced by endostatin
por: Gu, Yan-hui, et al.
Publicado: (2021) -
A new path for endostatin
por: Dove, Alan W.
Publicado: (2002)